PharmTech News

Articles

The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.

Pfizer Joins the Human Vaccines Project

The studies, conducted across eight countries with nearly 600 inflammatory bowel disease (IBD) patients, further support claims by Celltrion that Remsima is highly similar its reference product.

Studies Demonstrate Remsima Efficacy and Safety Following Switch from Infliximab

The new class of mAbs differs from approved anti-PD 1 mAbs because they do not block the PD-1-PD-L1 interaction.

Cellectis and MabQuest Collaborate on New Class of Monoclonal Antibodies

Sir Andrew Witty, CEO of GlaxoSmithKline, has said that he plans to retire from the company in March 2017, after nearly ten 10 years in the position.

GSK CEO to Retire in March 2017

The companies say the acquisition will assist in expediting the clinical development of RhoNova, a potential treatment targeting rhodopsin-linked autosomal dominant retinitis pigmentosa.

Spark Therapeutics Acquires Genable Technologies

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

GW Pharmaceuticals released Phase III trial results on Epidiolex, which was shown to decrease monthly convulsive seizures in children by 39%.

Investigational Cannabidiol Medication Shown to Reduce Seizures

The EC approved the merger on March 10, 2016 on the condition that Teva and Allergan divest certain assets in Europe.

European Commission Conditionally Approves Teva’s Acquisition of Allergan Generics

Hovione will operate a commercial-scale continuous manufacturing facility in New Jersey as part of an agreement with Vertex Pharmaceuticals.

Hovione Plans Commercial Continuous Manufacturing Facility

The company will showcase workflow solutions for sample prep and data analysis.

Thermo Scientific Displays New UHPLC-MS Workflows at Pittcon 2016

Clinical trials of Eli Lilly’s ixekizumab showed the drug displayed clinically meaningful improvements in patients with moderate-to-severe plaque psoriasis.

Bio/Pharma News